[Ocular toxoplasmosis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001284:Atrophy; D001528:Behcet Syndrome / Q000150:complications; D002648:Child; D002675:Child, Preschool; D005128:Eye Diseases / Q000151:congenital; D005260:Female; D005456:Fluorescent Dyes; D005654:Fundus Oculi; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007933:Leucomycins / Q000627:therapeutic use; D008266:Macula Lutea / Q000503:physiopathology; D008297:Male; D051379:Mice; D008875:Middle Aged; D009902:Optic Neuritis / Q000150:complications; D010781:Photography; D011739:Pyrimethamine / Q000627:therapeutic use; D012173:Retinitis / Q000150:complications; D014122:Toxoplasma / Q000302:isolation & purification; D014126:Toxoplasmosis, Ocular / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D014605:Uveitis / Q000150:complications; D014606:Uveitis, Anterior / Q000150:complications
D005456:Fluorescent Dyes; D007933:Leucomycins; D011739:Pyrimethamine